Eric Lattmann
Division of Pharmacy
School of Life and Health Sciences
Aston University
Birmingham
UK
Name/email consistency: high
- In-vitro and in-vivo antivenin activity of 2-[2-(5,5,8a-trimethyl-2-methylene-decahydro-naphthalen-1-yl)-ethylidene]-succinaldehyde against Ophiophagus hannah venom. Lattmann, E., Sattayasai, J., Sattayasai, N., Staaf, A., Phimmasone, S., Schwalbe, C.H., Chaveerach, A. J. Pharm. Pharmacol. (2010)
- In vivo evaluation of substituted 3-amino-1,4-benzodiazepines as anti-depressant, anxiolytic and anti-nociceptive agents. Lattmann, E., Lattmann, P., Boonprakob, Y., Airarat, W., Singh, H., Offel, M., Sattayasai, J. Arzneimittelforschung (2009)
- Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists. Lattmann, E., Singh, H., Boonprakob, Y., Lattmann, P., Sattayasai, J. J. Pharm. Pharmacol. (2006)
- Novel anti-bacterials against MRSA: synthesis of focussed combinatorial libraries of tri-substituted 2(5H)-furanones. Lattmann, E., Sattayasai, N., Schwalbe, C.S., Niamsanit, S., Billington, D.C., Lattmann, P., Langley, C.A., Singh, H., Dunn, S. Curr. Drug. Discov. Technol (2006)
- Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones. Lattmann, E., Dunn, S., Niamsanit, S., Sattayasai, N. Bioorg. Med. Chem. Lett. (2005)
- Synthesis and evaluation of N-(5-methyl-3-oxo-1,2- diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas as cholecystokinin antagonists. Lattmann, E., Sattayasai, J., Boonprakob, Y., Lattmann, P., Singh, H. Arzneimittelforschung (2005)
- Cytotoxicity of 3,4-dihalogenated 2(5H)-furanones. Lattmann, E., Kinchington, D., Dunn, S., Singh, H., Ayuko, W.O., Tisdale, M.J. J. Pharm. Pharmacol. (2004)
- Synthesis and evaluation of 5-arylated 2(5H)-furanones and 2-arylated pyridazin-3(2H)-ones as anti-cancer agents. Lattmann, E., Ayuko, W.O., Kinchinaton, D., Langley, C.A., Singh, H., Karimi, L., Tisdale, M.J. J. Pharm. Pharmacol. (2003)
- Synthesis and evaluation of N1-substituted-3-propyl-1,4-benzodiazepine-2-ones as cholecystokinin (CCK2) receptor ligands. Lattmann, E., Sattayasai, J., Billington, D.C., Poyner, D.R., Puapairoj, P., Tiamkao, S., Airarat, W., Singh, H., Offel, M. J. Pharm. Pharmacol. (2002)
- Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1). Lattmann, E., Billington, D.C., Poyner, D.R., Arayarat, P., Howitt, S.B., Lawrence, S., Offel, M. Drug. Des. Discov (2002)
- Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists. Lattmann, E., Billington, D.C., Poyner, D.R., Howitt, S.B., Offel, M. Drug. Des. Discov (2001)
- Design and synthesis of stable, water soluble radicals as potential anti-cancer agents. Lattmann, E., Begum, A., Plater, M.J. Drug. Des. Discov (1999)
- Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanones. Lattmann, E., Billington, D.C., Langley, C.A. Drug. Des. Discov (1999)
- Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanones. Lattmann, E., Billington, D.C., Langley, C.A. Drug. Des. Discov (1999)